ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | ![](/images/32027/67562_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ACKR1 | Atypical chemokine receptor 1 (Duffy blood group) | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16421/154116_A_9_11_selected_60x60.jpg) | ![](/images/17672/41563_B_8_2_rna_selected_60x60.jpg) | Mixed |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13819/30339_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images/5552/ihc_cell_selected_60x60.jpg) | ![](/images/5552/15784_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | ![](/images/62546/139288_A_2_8_selected_60x60.jpg) | ![](/images/62546/140548_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/1707/4765_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/15278/155554_A_1_7_selected_60x60.jpg) | ![](/images/15278/141832_A_1_5_rna_selected_60x60.jpg) | Tissue enriched |
ARL6IP5 | ADP-ribosylation factor-like 6 interacting protein 5 | Predicted membrane proteins
| | | | ![](/images/19321/43384_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37111/72071_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/10207/if_selected_60x60.jpg) | ![](/images/10207/ihc_cell_selected_60x60.jpg) | ![](/images/35116/84725_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images/49694/if_selected_60x60.jpg) | | ![](/images/29215/63696_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | ![](/images/3906/11752_A_2_5_rna_selected_60x60.jpg) | Expressed in all |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18176/42358_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39796/84042_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2428/6395_B_2_8_rna_selected_60x60.jpg) | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2492/6131_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/10088/26866_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/2507/6518_B_2_7_rna_selected_60x60.jpg) | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/61418/if_selected_60x60.jpg) | | ![](/images/28900/64793_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | ![](/images/2490/6649_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/22366/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14101/151887_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | ![](/images/9087/ihc_cell_selected_60x60.jpg) | ![](/images/9087/24244_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/43019/102123_B_5_8_rna_selected_60x60.jpg) | Expressed in all |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48319/122922_A_1_10_selected_60x60.jpg) | ![](/images/48319/122919_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42348/146593_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13166/30676_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN17 | Claudin 17 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45903/152525_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13243/28311_B_2_5_rna_selected_60x60.jpg) | Group enriched |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | ![](/images/2610/6436_B_1_2_rna_selected_60x60.jpg) | Mixed |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13063/32106_B_1_2_rna_selected_60x60.jpg) | Mixed |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | ![](/images/14704/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14704/33784_A_5_4_rna_selected_60x60.jpg) | Tissue enhanced |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/52338/123160_A_4_4_rna_selected_60x60.jpg) | Tissue enriched |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32017/139602_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/9492/155650_A_8_3_rna_selected_60x60.jpg) | Expressed in all |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33671/76711_B_9_7_rna_selected_60x60.jpg) | Group enriched |
DERL2 | Derlin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/37287/132043_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
DRAM1 | DNA-damage regulated autophagy modulator 1 | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44812/105575_B_3_8_rna_selected_60x60.jpg) | Expressed in all |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/13774/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13774/33100_B_8_2_rna_selected_60x60.jpg) | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/25229/61162_A_3_1_rna_selected_60x60.jpg) | Mixed |
ENDOD1 | Endonuclease domain containing 1 | Plasma proteins Predicted membrane proteins
| | ![](/images/8932/1395_H7_1_selected_60x60.jpg) | | ![](/images/8932/26759_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67632/156995_A_6_2_rna_selected_60x60.jpg) | Tissue enriched |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49244/122475_B_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/6970/19466_B_8_2_rna_selected_60x60.jpg) | Mixed |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/35202/ihc_cell_selected_60x60.jpg) | ![](/images/35202/135517_A_5_5_rna_selected_60x60.jpg) | Tissue enriched |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8441/22353_A_6_5_rna_selected_60x60.jpg) | Tissue enriched |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22725/151909_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/8338/ihc_cell_selected_60x60.jpg) | ![](/images/8338/23048_A_6_1_rna_selected_60x60.jpg) | Expressed in all |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/14765/if_selected_60x60.jpg) | ![](/images/14765/ihc_cell_selected_60x60.jpg) | ![](/images/14765/33832_B_7_4_rna_selected_60x60.jpg) | Mixed |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | ![](/images/7319/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7318/20195_A_3_4_rna_selected_60x60.jpg) | Group enriched |